首页> 外文期刊>Antimicrobial agents and chemotherapy. >Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele
【24h】

Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele

机译:唑菌氏菌菌抗性的渐进式分散性:用CYP51A TR46 Y121F M172I T289A等位基因对A. Fumigatus菌株感染急性髓性白血病患者的致命侵袭性曲霉病

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with hematologic malignancies as well as allogeneic hematopoietic stem cell transplantation (HSCT) patients are at high risk for invasive aspergillosis. Here, we report a culture-and autopsy-proven fatal invasive aspergillosis in an allogeneic HSTC patient which he developed despite posaconazole prophylaxis. The agent was determined to be an azole-resistant Aspergillus fumigatus strain bearing the cyp51A mutation combination TR46 Y121F M172I T289A. At increasing frequency, the azole resistance of A. fumigatus is being reported globally, limiting treatment options and complicating regimens.
机译:患有血液学恶性肿瘤的患者以及同种异体造血干细胞移植(HSCT)患者的侵袭性抑制患者的风险高。 在这里,我们报告了养殖和尸检丧失的致命侵袭性曲霉病,其同种异体的HSTC患者,他尽管posaconazole预防。 该试剂被测定为含有CYP51A突变组合TR46 Y121F M172I T289A的抗唑抗性曲霉菌菌株。 在频率的增加时,A. fumigatus的邻唑抗性正在全球报告,限制治疗方案和复杂的方案。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号